MBX Biosciences MBX
NASDAQ MBX
$53.93 +0.43 (+0.80%)
At close: Oct 21, 2026 · 4:00 PM EDT

MBX Biosciences (MBX) Operating Leases (2023 - 2026)

Updated

MBX Biosciences' Operating Leases came in at $2.71 million for Q2 2026, up 429.3% from $512,000 a year earlier and up 618.8% from the prior quarter.

Analysis

MBX Biosciences (MBX) Operating Leases (2023 - 2026) Analysis & Trends

At the end of FY2025, MBX Biosciences' Operating Leases was $424,000.

  • Going back by year, Operating Leases was $171,000 in FY2023.
  • Business Quant data shows MBX's Operating Leases at $377,000 (Q1 2026), $424,000 (Q4 2025) and $469,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 MBX Biosciences 2.57 Bn 944.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.71 Mn
Mar 31, 2026 377,000.00
Dec 31, 2025 424,000.00
Sep 30, 2025 469,000.00
Jun 30, 2025 512,000.00
Sep 30, 2024 44,000.00
Dec 31, 2023 171,000.00
API Access

MBX Biosciences Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=MBX&period=max&api_key=YOUR_API_KEY